July 1, 2013
Luxembourg (1 July 2013) – ConvaTec, a privately-held developer and marketer of innovative medical technologies, today announced that John Cannon has been named acting Chief Financial Officer of the company.
Mr. Cannon succeeds Edward Borkowski, who has left the company.
“I would like to thank Ed for his contributions to ConvaTec’s success over the past year and wish him well in the future,” said Ken Berger, CEO of ConvaTec.
Mr. Cannon is currently Vice President, Finance, for ConvaTec’s global Operations, which includes manufacturing, and for its Asia-Pacific and EMEA regions.
Mr. Cannon previously was with PMC Treasury, a financial advisory firm for private-equity sponsored companies, and was the senior financial officer with Singer Sewing. Earlier, he spent fifteen years in banking with Bankers Trust/Deutsche Bank, including eight years in Asia-Pacific. He has a BS degree in physics and economics from Haverford College and an MBA from New York University’s Stern School of Business.
ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key focus areas – Ostomy Care, Wound Therapeutics, Continence and Critical Care, and Infusion Devices – ConvaTec products support healthcare professionals from the hospital to the community health setting. The company is owned by Nordic Capital and Avista Capital Partners.